GeneTex
Events
-
Webinar - Genetic and Metabolic Determinants of Tumor Evolution and Metastasis
Speaker: Bryan Duy-Anh Ngo, Ph.D.
Dr. Ngo’s research examines the complex interplay between genomic instability, nutrient constraints, and metabolic synthetic processes that impacts a cancer cell’s ability to proliferate in diverse metastatic tissue environments. He will describe two independent studies that (i) connect a form of genetic instability with its causal role in inflammation-driven metastasis, and (ii) uncover a novel therapeutic paradigm that exploits the link between extracellular nutrient availability and cell-intrinsic serine synthesis in brain metastases. Dr. Ngo’s work provides new insight into the mechanisms driving metastasis and how this could lead to innovative therapies. -
Webinar - Discovery of Novel Antiviral Agents Against Human Pathogenic Viruses: A Tale of Two Emerging Viruses – SARS-CoV-2 and Zika Virus
Speaker: Francois Jean, Ph.D.
Dr. Jean will discuss his work with novel small-molecule inhibitors and protein-based therapeutics that function against human pathogenic viruses of global public health concern, including SARS-CoV-2 and Zika virus. He will further explain the importance of his research findings for (i) generating effective tools for dissecting pathways in vivo, (ii) defining the biological impact of new therapeutics, and (iii) generating insights into clinical approaches for treating viral diseases caused by emerging human coronaviruses and flaviviruses. -
Webinar - Inflammation, Infection, and Brain: Neuro-immune communication
Speaker: Dr. Chia-Yi Lin, Ph.D.
Dr. Lin will present an overview of neuro-immune communication and an introduction to the impacts of COVID-19 on neurological complications. The webinar objectives include Neuro-immune communication, Neurodegenerative disorders and the impacts of SARS-CoV-2 infection on neurological complications. -
Webinar - The ALS-Reproducible Antibody Platform (ALS-RAP): Identification of high-quality antibodies for ALS research
Speaker: Carl Laflamme, Ph.D.
Dr. Laflamme will discuss his published work describing the systematic assessment of antibodies against the C9ORF72 protein as part of ALS-RAP. He will then present intriguing data regarding C9ORF72 biology in macrophages, and will introduce his very exciting and potentially revolutionary efforts to expand the ALS-RAP methodology for antibodies against additional ALS disease proteins as well as those of other neurodegenerative disorders.
